Surfing the MASH Tsunami

Surfing the MASH Tsunami

Driving the Discussion in Fatty Liver Disease. Join hepatology researcher and Key Opinion Leader Jörn Schattenberg, Liver Wellness Advocate Louise Campbell, and Forecasting and Pricing Guru Roger Green and a global group of Key Opinion Leaders and patient advocates as they discuss key issues in Fatty Liver disease, including epidemiology, drug development, clinical pathways, non-invasive testing, health economics and regulatory issues, from their own unique perspectives on the Surfing the MASH Tsunami podcast. #MASH #MAFLD #FattyLiver #livertwitter #AASLD #GlobalLiver #NoNASH #EASL

Tämä podcast on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi podcastin jaksot saattavat sisältää mainontaa.

Jaksot(1073)

S3-E62.1 - Year-End Interview with Mazen Noureddin

S3-E62.1 - Year-End Interview with Mazen Noureddin

Send us Fan Mail In the Season 3 NAFLD Year-in-Review conversations series, Surfers Jörn Schattenberg, Louise Campbell and Roger Green embark on a string of interviews with a handful of Key Opinion Le...

28 Joulu 202230min

S3-E62 - 2022 NAFLD Year-in-Review Interview Series, Part 2

S3-E62 - 2022 NAFLD Year-in-Review Interview Series, Part 2

Send us Fan Mail The latter half of December marks the Surfing the NASH Tsunami annual NAFLD Year-in-Review. In Part 2 of this Season 3 finale, Surfers Jörn Schattenberg, Louise Campbell and Roger Gre...

26 Joulu 20221h 5min

S3-E60.5 - Madrigal Announcement on Resmetirom: Combination Therapy and Closing Takeaways

S3-E60.5 - Madrigal Announcement on Resmetirom: Combination Therapy and Closing Takeaways

Send us Fan Mail In a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced positive topline results from the pivotal Phase 3...

26 Joulu 202219min

S3-E60.4 - Madrigal Announcement on Resmetirom: Basic Science and Impact on Future Use of NITs

S3-E60.4 - Madrigal Announcement on Resmetirom: Basic Science and Impact on Future Use of NITs

Send us Fan Mail In a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced positive topline results from the pivotal Phase 3...

26 Joulu 202215min

S3-E60.3 - Madrigal Announcement on Resmetirom: Diving into Implications

S3-E60.3 - Madrigal Announcement on Resmetirom: Diving into Implications

Send us Fan Mail In a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced positive topline results from the pivotal Phase 3...

24 Joulu 202215min

S3-E60.2 - Madrigal Announcement on Resmetirom: First Reactions and Differing Perspectives

S3-E60.2 - Madrigal Announcement on Resmetirom: First Reactions and Differing Perspectives

Send us Fan Mail In a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced positive topline results from the pivotal Phase 3...

24 Joulu 202215min

S3-E60.1 - Donna Cryer on the Far-Reaching Implications of Madrigal’s Emerging Story on Resmetirom

S3-E60.1 - Donna Cryer on the Far-Reaching Implications of Madrigal’s Emerging Story on Resmetirom

Send us Fan Mail In a monumental moment in the never-ending pursuit of putting a major dent in Fatty Liver disease, Madrigal Pharmaceuticals announced positive topline results from the pivotal Phase 3...

24 Joulu 202222min

S3-E61 - NASH-TAG 2023 Preview with Stephen Harrison

S3-E61 - NASH-TAG 2023 Preview with Stephen Harrison

Send us Fan Mail NASH-TAG 2023 co-course director Stephen Harrison and scientific advisory board committee member Jörn Schattenberg join Louise Campbell and Roger Green to preview what is shaping to b...

23 Joulu 202239min

Suosittua kategoriassa Tiede

tiedekulma-podcast
rss-mita-tulisi-tietaa
utelias-mieli
rss-hereilla
mielipaivakirja
radio-antro
rss-poliisin-mieli
rss-astetta-parempi-elama-podcast
rss-ylistys-elaimille
docemilia
vinkista-vihia
filocast-filosofian-perusteet
menologeja-tutkimusmatka-vaihdevuosiin
rss-duodecim-lehti
rss-totuuden-liepeilla